Merck logo

Senior Director, Clinical Science, Oncology Early Development (Hybrid)

Merck

Rahway, NJ; Boston, MA; Upper Gwynedd, PA; South San Francisco, CAHybridPosted 2 days ago$210,400.00 - $331,100.00
Full TimeDirector & AboveClinical DevelopmentPharmaceutical
Original posting ↗

Summary

The Senior Director, Clinical Science, Oncology Early Development provides strategic Clinical Science leadership for novel assets from candidate transition through first-in-human development and clinical proof-of-concept. Reporting to the Executive Director, this role applies deep expertise in early-phase oncology, translational medicine, biomarker strategy, and first-in-human trial design to shape development plans and enable data-driven decision-making across the early oncology portfolio.

Job description

Key Responsibilities

  • Provide strategic Clinical Science leadership across Oncology Early Development, including multiple studies, programs, and assets.
  • Contribute to early clinical development strategy from candidate transition through first-in-human evaluation and clinical proof-of-concept.
  • Integrate disease biology, mechanism of action, translational evidence, competitive landscape, and emerging data to identify development opportunities, risks, and key decision points.
  • Establish and advance consistent Clinical Science standards for early development planning, medical data review, dose-escalation meetings, data interpretation, and key deliverables.
  • Guide interpretation of clinical data across studies, cohorts, and assets.
  • Contribute scientific perspective to protocol development, amendments, study design, endpoint selection, eligibility criteria, and biomarker strategy.
  • Contribute Clinical Science expertise to portfolio discussions, governance reviews, and senior leadership meetings.
  • Provide direct management for Directors, Principal Scientists, and Clinical Scientists.
  • Support development of Clinical Science talent through coaching, mentoring, and feedback.
  • Partner closely with Clinical Operations, Regulatory Affairs, Biostatistics, Data Management, Drug Safety and Pharmacovigilance, Translational Medicine, and Medical Affairs.
  • Ensure Clinical Science activities comply with regulatory requirements, company policies, and established procedures.

Education

Advanced scientific or healthcare degree required (e.g., PhD, PharmD), or equivalent, with 8+ years of pharmaceutical, clinical drug development, and/or medical field experience preferred. Master's degree, preferably in life sciences, with 12+ years of experience. Bachelor's degree, preferably in life sciences, with 15+ years of experience.

Experience

  • Significant experience in Clinical Development, Clinical Science, clinical drug development, or a related function within the pharmaceutical or biotechnology industry, with substantial responsibility in early-phase development.
  • Demonstrated leadership of first-in-human and early-phase oncology studies, including dose escalation, dose optimization, cohort expansion, and proof-of-concept planning.
  • Deep understanding of oncology disease biology, novel mechanisms and modalities, translational medicine, biomarker-driven development, PK/PD, and safety and tolerability assessment.
  • Strong understanding of clinical trial design, clinical development strategy, clinical data review, and interpretation of oncology data.
  • Experience contributing to protocols, regulatory submissions, safety reviews, health authority interactions, governance discussions, and cross-program planning.
  • Experience working effectively within cross-functional teams in a matrixed environment.
  • Demonstrated ability to integrate information across studies and programs to support scientific and business decision-making.
  • Excellent communication, influence, and executive presentation skills.
  • Demonstrated people leadership experience, including management, coaching, and development of scientific staff.

Requirements

  • Advanced scientific or healthcare degree required (e.g., PhD, PharmD), or equivalent
  • 8+ years of pharmaceutical, clinical drug development, and/or medical field experience preferred (advanced degree)
  • Master's degree with 12+ years of pharmaceutical, clinical drug development, and/or medical field experience
  • Bachelor's degree with 15+ years of pharmaceutical, clinical drug development, and/or medical field experience
  • Significant experience in Clinical Development, Clinical Science, clinical drug development, or related function in pharmaceutical or biotechnology industry
  • Substantial responsibility in early-phase development
  • Demonstrated leadership of first-in-human and early-phase oncology studies
  • Experience with dose escalation, dose optimization, cohort expansion, and proof-of-concept planning
  • Deep understanding of oncology disease biology, novel mechanisms and modalities, translational medicine, biomarker-driven development, PK/PD, and safety assessment
  • Strong understanding of clinical trial design, clinical development strategy, clinical data review, and interpretation of oncology data
  • Experience contributing to protocols, regulatory submissions, safety reviews, health authority interactions, governance discussions, and cross-program planning
  • Experience working effectively within cross-functional teams in a matrixed environment
  • Demonstrated ability to integrate information across studies and programs
  • Excellent communication, influence, and executive presentation skills
  • Demonstrated people leadership experience, including management, coaching, and development of scientific staff

Benefits

  • Medical, Dental & Vision
  • 401(k) Matching
  • Retirement Benefits
  • Paid Holidays
  • Vacation
  • Compassionate & Sick Days
  • Annual Bonus
  • Long-Term Incentive

Company overview

Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.